An increase in plasma fibrin degradation products can be seen in a number of conditions, some of which may co-exist.
Conditions that may be associated with elevation in fibrin degradation products:
(1) disseminated intravascular coagulation (DIC)
(2) thrombosis
(3) trauma or recent surgery
(4) hematoma
(5) massive hydrothorax/ascites
(6) fibrinolytic therapy
(7) liver impairment
(8) renal impairment
(9) malignancy
To read more or access our algorithms and calculators, please log in or register.
Specialty: Hematology Oncology
